Is W. R. Berkley Corporation (WRB) overvalued or fairly valued?

MarketChacha shows W. R. Berkley Corporation's valuation in context — a trailing P/E of about 14.6, a forward P/E of about 14.3 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

Does W. R. Berkley Corporation's reported profit turn into cash?

Over 3 years, operating cash flow fully covered reported profit — earnings are backed by real cash. MarketChacha computes this cash-conversion check (2.07×) from reported figures — education, not a rating.

What is W. R. Berkley Corporation's revenue?

W. R. Berkley Corporation reported revenue of $14.7B for FY2025, with net profit of $1.8B, per official filings.

What is the share price of W. R. Berkley Corporation (WRB)?

W. R. Berkley Corporation last traded at $69.14 (-0.5% on the day), as of 9/4/2026 — a delayed quote shown for education, not investment advice.

W. R. Berkley Corporation

WRB · NYSE · Financials · United States

Snapshot

TickerWRB

ExchangeNYSE

SectorFinancials

IndustryInsurance - Property & Casualty

CountryUnited States

Employees8,804

HeadquartersGreenwich, United States

Websitewww.berkley.com

Filings tracked14

About W. R. Berkley Corporation

W. R. Berkley Corporation, an insurance holding company, operates as a commercial line writer worldwide. The company operates through Insurance and Reinsurance & Monoline Excess segments. The Insurance segment underwrites commercial insurance business, including excess and surplus lines, admitted lines, and specialty personal lines. This segment also provides accident and health insurance and reinsurance products; insurance for commercial risks; casualty and specialty environmental products; insurance coverages for fine arts and jewelry exposures; excess liability and inland marine coverage for small to medium-sized insureds; and commercial general liability, umbrella, professional liability, directors and officers, commercial property, and surety products, as well as products for technology, and life sciences and travel industries. In addition, it offers cyber risk solutions; crime and fidelity insurance products; medical professional coverages; workers' compensation insurance products; management liability and general insurance products; personal lines insurance solutions, including home, condo/co-op, auto, fine arts and collectibles, liability, collector vehicle, and recreational marine; law enforcement, public officials and educator's legal, and employment practices liability, as well as incidental medical, property, and crime insurance products; at-risk and alternative risk insurance program management services; professional liability; energy and marine risks; and insurance products to the Lloyd's marketplace. The Reinsurance & Monoline Excess segment provides treaty and facultative reinsurance solutions; property and casualty reinsurance products; facultative reinsurance products include automatic, semi-automatic, and individual risk assumed reinsurance; and turnkey products, such as cyber, employment practices liability insurance, liquor liability insurance and violent events. The company was founded in 1967 and is headquartered in Greenwich, Connecticut.

Who owns it

Insiders26.4%
Institutions73.6%
Public & other0.0%

1,283 institutional holders

Ownership breakdown from public market data.

Top holders

Mitsui Sumitomo Insurance Co Ltd15.83%
Blackrock Inc.5.91%
Vanguard Capital Management LLC5.03%
Vanguard Portfolio Management LLC3.92%
State Street Corporation3.81%
Geode Capital Management, LLC2.23%
Morgan Stanley2.22%
Kayne Anderson Rudnick Investment Management LLC1.72%

Largest institutional holders — last updated 6/30/2026.

Forensic scorecard

No major accounting red flags in the fundamentals we have — profit is backed by cash and returns look healthy.

Cash conversion2.07×

Over 3 years, operating cash flow fully covered reported profit — earnings are backed by real cash.

Net margin trend11.4% → 12.1%

Margin has held broadly steady over the period — stable profitability.

Return on equity18.3%

Latest ROE of 18.3% — capital is generating a healthy return.

Growth qualityrev 10% · PAT 13%

Profit growth is broadly tracking revenue growth — the earnings trend looks operational rather than one-off.

Computed by MarketChacha from reported figures (SEC XBRL). Education, not a rating or recommendation.

What's expected next

Next quarter

Rev $3.2B · EPS 1.21

Est. earnings growth +6.8%

Next fiscal year

Rev $13.3B · EPS 4.84

Est. earnings growth -0.7%

Analyst consensus estimates — not the company's own guidance.

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Financials at a glance

Source: SEC XBRL

Annual

Quarterly · last 8

Revenue (FY2025)

$14.7B

Net margin

12.1%

ROE

18.3%

Revenue CAGR (2y)

+10.1%

Profit CAGR (2y)

+13.5%

EPS (FY2025)

4.45

Net profit (FY2025)

$1.8B

Ask MarketChacha about WRB

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Financials

Yearly

Period	Revenue	Net profit	EPS	Net margin	ROE
FY2025	$14.7B	$1.8B	4.45	12.1%	18.3%
FY2024	$13.6B	$1.8B	4.36	12.9%	20.9%
FY2023	$12.1B	$1.4B	3.37	11.4%	18.5%

Quarterly

Period	Revenue	Net profit	EPS	Net margin
2026Q2	$3.7B	$452.3M	1.15	12.2%
2026Q1	$3.7B	$515.2M	1.31	14.0%
2025Q3	$3.8B	$511.0M	1.28	13.6%
2025Q2	$3.7B	$401.3M	1.00	10.9%
2025Q1	$3.5B	$417.6M	1.04	11.8%
2024Q3	$3.4B	$365.6M	0.91	10.8%
2024Q2	$3.3B	$371.9M	0.92	11.2%
2024Q1	$3.3B	$442.5M	1.09	13.6%
2023Q3	$3.0B	$333.6M	0.82	11.0%
2023Q2	$3.0B	$356.3M	0.87	11.9%
2023Q1	$2.9B	$294.1M	1.06	10.2%

Figures as reported, in reporting currency. Source: SEC XBRL.

Filings & announcements

2026

10-Q filing
SEC7/31/2026
8-K — Results of operations, Exhibits
SEC7/20/2026material
8-K — Executive/director change
SEC6/26/2026material
8-K — Material agreement, Material financial obligation, Exhibits
SEC6/11/2026material
8-K — Other events, Exhibits
SEC6/10/2026material
8-K — Shareholder vote results
SEC6/5/2026material
10-Q filing
SEC5/1/2026
8-K — Results of operations, Exhibits
SEC4/21/2026material
10-K filing
SEC2/27/2026
8-K — Results of operations, Exhibits
SEC1/26/2026material

2025

8-K — Other events, Exhibits
SEC12/5/2025material
10-Q filing
SEC11/3/2025
8-K — Results of operations, Exhibits
SEC10/20/2025material
10-Q filing
SEC8/4/2025

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed market data) are delayed and shown for reference only. Verify with the linked sources before acting.